Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540–556.e25 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo, C. C. et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat. Rev. Urol. https://doi.org/10.1038/s41585-023-00847-7 (2024).

Article  PubMed  Google Scholar 

Guo, C. C. et al. Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer. Eur. Urol. 70, 611–620 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Ahmadie, H. A. et al. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. Nat. Genet. 48, 356–358 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo, C. C. et al. Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer. Cell Rep. 27, 1781–1793.e4 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, G. et al. Urothelial-to-neural plasticity drives progression to small cell bladder cancer. iScience 23, 101201 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McFadden, J. et al. Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy. Urol. Oncol. 42, 69.e11–69.e16 (2024).

Article  CAS  PubMed  Google Scholar 

Ramos, P. et al. Prognostic impact of variant histology in bladder cancer: would early and aggressive treatment shift the paradigm? Urol. Oncol. 42, 161.e1–161.e8 (2024).

Article  PubMed  Google Scholar 

Claps, F. et al. Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. BJU Int. 132, 170–180 (2023).

Article  PubMed  Google Scholar 

Ginsburg, K. B. et al. Oncologic outcomes of cT1 and cT2 micropapillary variant compared with cT1 and cT2 conventional urothelial carcinoma treated with radical cystectomy. Urol. Pract. 9, 396–404 (2022).

Article  PubMed  Google Scholar